N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide (Compound)

Pubchem:PUBCHEM:16004692

Id:047a9673-e843-50f9-a61b-dee3c3600a96

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide.

Results found

Linked to

	Label	Description
	N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide in similarity relationship with Gliclazide Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	deserpidine in similarity relationship with N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide negatively regulates ALCAM Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide positively regulates GCLC Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide positively regulates CP Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide positively regulates NVL Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide negatively regulates MAL Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide negatively regulates GNG11 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide negatively regulates MARCKS Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	SID11113933 in similarity relationship with N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide in similarity relationship with Gliclazide

Knowledge Graph Assertion (Entity type)